摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3aR,5aS,7S,8bR)-8-Butyl-7-methyl-3,3a,4,5,5a,6,7,8b-octahydro-1H-cyclopenta[de]quinazolin-2-ylideneamine; compound with nitric acid | 202646-37-5

中文名称
——
中文别名
——
英文名称
(3aR,5aS,7S,8bR)-8-Butyl-7-methyl-3,3a,4,5,5a,6,7,8b-octahydro-1H-cyclopenta[de]quinazolin-2-ylideneamine; compound with nitric acid
英文别名
(1S,4R,10S,12R)-9-butyl-10-methyl-5,7-diazatricyclo[6.3.1.04,12]dodeca-5,8-dien-6-amine;nitric acid
(3aR,5aS,7S,8bR)-8-Butyl-7-methyl-3,3a,4,5,5a,6,7,8b-octahydro-1H-cyclopenta[de]quinazolin-2-ylideneamine; compound with nitric acid化学式
CAS
202646-37-5
化学式
C15H25N3*HNO3
mdl
——
分子量
310.396
InChiKey
UVZNDTFFVRXAFI-QOYNJTQNSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.65
  • 重原子数:
    22.0
  • 可旋转键数:
    3.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    111.28
  • 氢给体数:
    4.0
  • 氢受体数:
    3.0

反应信息

点击查看最新优质反应信息

文献信息

  • Chiral [η6-Arene-Cr(CO)3] Complexes as Synthetic Building Blocks: A Short Enantioselective Total Synthesis of (+)-Ptilocaulin
    作者:Kurt Schellhaas、Hans-Günther Schmalz、Jan W. Bats
    DOI:10.1002/(sici)1521-3765(199801)4:1<57::aid-chem57>3.0.co;2-h
    日期:1998.1
    An enantioselective total synthesis of the marine natural product (+)-ptilocaulin is described. The synthesis starts from [anisole-Cr(CO)(3)], which is converted to [2-trimethylsilylanisole - Cr(Co)(3)] (greater than or equal to 99 % ee) by enantioselective deprotonation/silyLation and recrystallization. After attachment of a 2-butenyl side-chain, nucleophile addition (2-lithio-1,3-dithiane) followed by treatment with chloratrimethylsilane and hydrolysis leads to (5S,6S)-6-((E)-but-2-enyl)-5-[1,3]-dithian-2-yl-2-trimethylsilylcyclohex-2-enone with complete chirality transfer. This compound, which was characterized by X-ray crystallography, is transformed into (5 xi,6S,7aS)-5-butpl-6-methyl-1,2,5,6,7,7a-hexahydro-inden-4-one, a ptilocaulin precursor known from the literature, by a 4-step sequence consisting of diastereoselective 1,4-addition, ultrasound-assisted desulfurization/hydrogenation (Raney Ni) and aldol cyclization. The target molecule was prepared in both racemic and optically active form. The X-ray crystal structure of rac-ptilocaulin nitrate shows flat ribbons of homochiral units (parallel double chains) connected by an interesting pattern of hydrogen bonds between the guanidinium and the nitrate ions. A different mode of hydrogen bonding resulting in the formation of helical monochains was found in the solid-state structure of (+)-ptilocaulin co-crystallized with about 29 % of its C-3a epimer.
  • ASAOKA, MORIO;SAKURAI, MASAHITO;TAKEI, HISASHI, TETRAHEDRON LETT., 31,(1990) N3, C. 4759-4760
    作者:ASAOKA, MORIO、SAKURAI, MASAHITO、TAKEI, HISASHI
    DOI:——
    日期:——
查看更多

同类化合物

(2R,3S,5R)-5-(4-氨基-7H-吡咯[2,3-D]嘧啶-7-基-2 -(羟甲基)四氢呋喃-3-醇 鲁索替尼 鲁索利尼杂质C 酸蓝129:1 迪高替尼 诺那吡胺 螺[4.4]壬烷-1-酮,6-氨基-,(5S,6S)- 苯酚,2,4-二氯-5-肼-,单盐酸 苯并呋喃,2,3-二氢-3-(1-甲基乙基)- 芦可替尼杂质5 芦可替尼杂质3 芦可替尼杂质2 聚(氧代-1,2-乙二基),a-甲基-w-[[3,4,4,4-四氟-2-[1,2,2,2-四氟-1-(三氟甲基)乙基]-1,3-二(三氟甲基)-1-丁烯-1-基]氧代]- 维贝格龙 磷酸鲁索替尼 甲基7-(2-甲氧基乙基)-1,3-二甲基-2,4-二羰基-2,3,4,7-四氢-1H-吡咯并[2,3-D]嘧啶-6-羧酸酯 甲基6,7-二氢-5H-吡咯并[3,4-D]嘧啶-2-甲酸基酯 氰基酰胺,(1-甲基-2-吡咯烷亚基)-(9CI) 杂质TFTB 替诺福韦杂质113 托法替布杂质ZJT2-I 托法替尼杂质28 托法替尼杂质2 托伐替尼杂质T 异丙基2-氨基-4-甲氧基-7h-吡咯并[2,3-d]嘧啶-6-羧酸 巴里替尼杂质5 巴瑞替尼杂质9 巴瑞替尼 巴瑞克替尼杂质 巴瑞克替尼中间体3 巴瑞克替尼中间体1 外消旋鲁替替尼-d8 培美酸 培美曲塞杂质 吡啶,1-[(2,5-二甲基苯基)甲基]-1,2,3,6-四氢- 吡咯并[1,2-a]嘧啶-3-羧酸 吡咯并[1,2-F]嘧啶-3-甲酸乙酯 吡咯并[1,2-C]嘧啶-4-腈 吡咯并[1,2-A]嘧啶-6-羧酸 吡咯并[1,2-A]嘧啶-6-甲醛 叔丁基2-氨基-4-氯-5H-吡咯并[3,4-D]嘧啶-6(7H)-羧酸酯 叔丁基-4-氯-2-吗啉代-7H-吡咯并[2,3-D]嘧啶-7-甲酸甲酯 十二烷-1,12-二基二(苯甲基二甲基铵)二氯化 化合物PFE-360 亚乙基,2-氨基-1-(乙酯基<乙氧羰基>)-2-(甲酰基亚氨基)-,(2Z)-(9CI) 二环[2.2.1]庚-5-烯-2-羧酸,丁基酯,(1R,2R,4R)- [4-(1H-吡唑-4-基)-7H-吡咯并[2,3-D]嘧啶-7-基]甲基特戊酸酯 [3-(4-氨基-7H-吡咯并[2,3-d]嘧啶-7-基)环戊基]甲醇 [1-(乙基磺酰基)-3-[4-(7H-吡咯并[2,3-d]嘧啶-4-基)-1H-吡唑-1-基]氮杂环丁烷-3-基]乙腈磷酸盐 S-鲁索替尼